Written by Ad OpsOrigin and Breeding History
Dave's Who 13 is a mostly sativa cultivar bred by James Loud Genetics, a California-based breeder renowned for rigorous phenotype selection and high-terpene modern hybrids. The strain name hints at a selection-driven project, with the '13' likely signifying a keeper phenotype from a larger hunt rather than a reference to a specific parental cross. In breeder circles, this naming convention is common for lines where the standout expression is identified by a number after a wide seed run. As of 2024, the breeder has not publicly released a definitive parental pedigree for Dave's Who 13.
James Loud Genetics has consistently targeted market-ready chemovars with strong resin production, bright terpene expression, and vigorous growth. Their selections often emphasize sativa-leaning effects that remain functional and creative, a niche increasingly in demand among daytime consumers. This fits the reported experience of Dave's Who 13, which is frequently described by growers as a rapid-onset, mentally lifting cultivar with an energetic push. Early adopter reports highlight its clarity over couchlock, aligning with its mostly sativa heritage.
The project's development likely involved testing across multiple environments to stress-test stability and find the best-performing cut. A phenotype tagged #13 would be chosen for attributes like consistent yield, terpene intensity, and structural resilience. Breeders typically quantify these results through yield per square foot, total terpene percentage, and uniformity of plant height across replicates. While exact internal metrics are not public, the commercial-ready polish of Dave's Who 13 suggests it hit those targets.
Market interest in sativa-dominant varieties has grown as consumers diversify beyond heavy indica-dominant profiles. In several U.S. markets between 2020 and 2023, lab averages for legal flower hovered near 19–22% THC, making high-terp sativas with distinctive flavor profiles more competitive regardless of absolute potency. Dave's Who 13 appears to be positioned precisely for that opportunity space. Its breeder pedigree and traction among connoisseur growers underscore that intent.
Because strains evolve through selections and backcrosses, living genetic lines are more like families than fixed recipes. Dave's Who 13 should be understood as a stabilized selection within that family, not a static chemical formula. This contextual view explains why different grows can present subtly different terpenes or aromas while retaining a recognizable core character. For consumers and cultivators, this history signals a balance of innovation and repeatable performance.
Genetic Lineage and Phenotypic Expectations
The exact parentage of Dave's Who 13 has not been formally published by James Loud Genetics as of the latest information. However, multiple grow logs and sensory notes from cultivators describe traits strongly associated with modern sativa-forward lines. These include a pronounced vertical stretch in early bloom, narrow-to-medium leaf morphology, and a terpene profile that often leans terpinolene, limonene, or pinene. Collectively, these clues point to ancestry that draws from Haze-like or tropical sativa families.
Sativa-dominant hybrids commonly exhibit a 1.5x to 3x stretch upon transition to 12/12 light cycles. Growers who ran Dave's Who 13 in controlled indoor conditions frequently report a 1.8x–2.4x stretch window when flipped at 12–16 inches of height. This trait guides training strategy and canopy management, with earlier topping and low-stress training favored over hard late defoliation. The plant’s internodal spacing is moderate, supporting good light penetration with proper pruning.
Buds typically present as elongated spears rather than compact golf balls, a hallmark of sativa-leaning structure. Calyx-to-leaf ratio is reported as favorable, simplifying trim work and improving bag appeal. Resin heads appear plentiful, with trichome density noted on sugar leaves and calyx tips by week 6–7 of bloom. Sativa-like foxtailing can occur under high PPFD or excessive heat, but this is manageable with environmental tuning.
Chemical expression in sativa-forward lines often favors monoterpenes that volatilize readily and express bright aromas. Observers describe Dave's Who 13 as citrus-herbal with occasional floral or pine lift, suggesting a mix where terpinolene or limonene may lead, with supporting alpha-pinene, beta-pinene, and beta-caryophyllene. Minor terpenes like ocimene and linalool may add nuance, especially in late flower. This structure aligns with a daytime, alert effect profile.
Because phenotype expression can vary by environment, expect some plasticity in aroma and yield across media and schedules. Coco and rockwool systems tend to drive faster growth and denser stacking if EC and VPD are tuned. Organic living soil may enhance terpene complexity at a modest trade-off in raw yield, a common pattern noted across sativa-dominant cultivars. Selecting the cultivation style that fits your goals will make the most of this line.
Botanical Appearance and Structure
Dave's Who 13 grows with medium vigor in vegetative stages, accelerating rapidly once established. Leaflets trend narrow to medium width with serrations that are clean and pronounced. Stems are moderately flexible, making the plant amenable to low-stress training without immediate risk of snapping. Internodes are spaced to allow airflow, which helps prevent moisture-related issues in dense canopies.
During pre-flower and early bloom, expect a pronounced apical drive. Primary colas reach for light, and side branches respond well to topping that redistributes auxin and builds a broader canopy. With a two-top or four-top strategy, plants fill a SCROG evenly in 10–14 days post-flip. This structure supports multiple mid-sized colas instead of a single giant spear, improving uniform ripening.
Flowers form as segmented spears with stacked calyxes that swell late, typically around weeks 7–9 of bloom. Trichome formation is evident by mid-flower, with sugar leaves frosting early and calyx heads swelling toward harvest. Pistil coloration shifts from bright white to amber-orange toward finish, but trichome color is the more reliable ripeness indicator. Fans often fade lime to golden yellow with proper nutrient drawdown.
In optimal conditions, the cultivar exhibits a healthy calyx-to-leaf ratio, easing trimming and improving visual appeal. Foxtailing can appear if canopy temperatures exceed 28–29°C under high PPFD, but mild stacking is not always detrimental and may be largely aesthetic. Stem strength is sufficient for most indoor runs, though late-season stakes or netting are recommended as colas pack on weight. Overall, the plant presents as elegant and orderly when trained early and fed consistently.
Aroma and Terpene Expression
Aroma development in Dave's Who 13 ramps up sharply after week 4 of bloom, intensifying into a complex citrus-herbal bouquet by week 7. Many growers report a dominant note of bright lemon or mixed citrus peel, often underpinned by green pine and fresh herbs. Secondary nuances can include floral lilac, sweet melon, or a faint tropical lift reminiscent of mango skin. On stem rubs, expect sharper pine-solvent facets, which soften into sweeter tones as flowers cure.
If terpinolene is prominent—as is common in many sativa-leaning lines—the nose will read as effervescent and high-tone. Terpinolene blends readily with limonene to suggest citrus soda, with pinene adding forest-clean accents. Beta-caryophyllene can lend a peppery base that stabilizes the bright top notes and improves persistence in the jar. This balance makes the aroma both immediately striking and shelf-stable over a proper cure.
Terpene intensity is sensitive to environmental conditions, especially late-flower heat and post-harvest handling. Total terpene content in high-performing sativa hybrids frequently lands between 1.5% and 3.0% by dry weight, with elite runs measuring above 3.5% under ideal conditions. While specific lab data for Dave's Who 13 are limited, its breeder reputation and grower feedback suggest it can compete in this range. Protecting terpenes during dry and cure is essential to preserve this expression.
Breaking the buds releases layers beyond the initial jar aroma. Some cuts reveal a distinct sweet-citrus hard candy note that sits atop a resinous, piney core. Others shift toward an herbaceous lemon-thyme with a whisper of floral sweetness. These differences reflect phenotypic nuance and grower technique rather than a fundamentally different chemotype.
Flavor and Combustion Character
On inhalation, Dave's Who 13 presents a crisp citrus entry with a clean pine snap, followed by light floral-herbal undertones. Vaporization at 175–190°C accentuates the lemon-lime and green apple-like brightness while preserving volatile monoterpenes. Combustion smoothness improves markedly after a slow cure, with peppery beta-caryophyllene notes emerging on the exhale. The finish tends to be refreshing rather than cloying.
Users often describe the mouthfeel as light to medium-bodied, lacking the heavy resinous coating common to some indica-leaning cultivars. This makes it a pleasant daytime profile, especially in portable vaporizers where flavor detail is most apparent. With joints or bowls, a white-to-light-gray ash indicates a clean mineral balance and thorough cure. Excessively dark ash usually points to rushed drying or residual moisture rather than genetics.
Terpene persistence is above average for a citrus-forward cultivar, holding flavor through multiple pulls. A jar with 58–62% relative humidity packs tends to maintain aromatic stability for 60–90 days if stored in the dark at 15–21°C. Past that window, expect top-note attenuation as monoterpenes volatilize, while spicier sesquiterpenes become more noticeable. Proper storage keeps the flavor closer to harvest quality for longer.
Cannabinoid Profile and Potency
Publicly available certificates of analysis (COAs) specific to Dave's Who 13 are scarce, which is not unusual for boutique or newly released cultivars. Nevertheless, sativa-dominant, modern U.S. genetics commonly test between 18% and 26% THC in regulated markets, with a mean near 20–22% in many statewide datasets from 2021–2023. Early grower and retailer anecdotes place Dave's Who 13 comfortably within this competitive band when properly grown and cured. Potency appears to be driven more by cultivation precision than by an inherent cap.
CBD content in high-THC sativa hybrids is typically negligible, often below 0.5%. Minor cannabinoids, especially CBG, can appear in the 0.2–1.0% range, adding to perceived clarity and focus in the effect profile. Trace THCV has been observed in some sativa families with African lineage, but without lab confirmation it is prudent to consider THCV as a possible trace rather than a defining feature. As lab testing becomes more widespread for this cultivar, a clearer distribution will emerge.
Total cannabinoids—the sum of THC, CBD, CBG, and others—frequently exceed 20% in well-grown modern sativa hybrids. In practical terms, this means a single 0.1 g inhaled dose may deliver 18–26 mg of delta-9 THC equivalency, a level adequate for strong effects in many users. For novice consumers, a 2–5 mg THC starting dose remains the standard harm-minimizing recommendation. Experienced consumers may titrate higher, but daytime clarity remains a core strength of this line when dosed modestly.
It is important to remember that potency statistics do not predict subjective effect quality on their own. Terpene composition modifies perceived intensity, onset speed, and duration; the so-called entourage effect is a useful heuristic in this context. For Dave's Who 13, the bright terpene cluster appears to enhance alertness and mood lift, helping the cultivar feel strong without being sedating. This interplay likely explains its reputation for a clear, productive headspace.
From a cultivation standpoint, environmental factors can move potency by several percentage points. Light intensity, canopy temperature, and nutrient balance—especially adequate nitrogen early and sufficient potassium late—contribute to cannabinoid synthesis. Over-fertilization or heat stress can depress total cannabinoids while degrading terpenes, leading to harsher smoke at the same nominal THC. Precision grows routinely outperform average runs by 10–20% in potency and terpene totals.
Terpene Profile and Minor Compounds
While definitive terpene data for Dave's Who 13 await broader third-party testing, its sensory signature aligns with several common sativa-forward chemotypes. The most likely dominant candidates are terpinolene or limonene, with significant contributions from alpha-pinene, beta-pinene, and beta-caryophyllene. Depending on the phenotype and environment, ocimene, linalool, and humulene may round out the profile. This mix supports a bright, uplifting aroma with a grounded spicy backbone.
In modern legal markets, the median total terpene content for top-shelf flower often falls between 1.5% and 2.5%, with exceptional cultivars surpassing 3.0%. Sativa-leaning cultivars that are terpinolene-dominant have been documented in the 1.3–2.8% total terpene range, with individual terpinolene values frequently 0.4–1.2%. Limonene, when co-dominant, often measures 0.3–0.8%. Pinene totals, split between alpha and beta isomers, commonly sit at 0.2–0.6% combined.
These numbers matter because individual terpenes correlate with perceived effects. Pinene has been associated with alertness and potential short-term memory support, while limonene correlates with elevated mood and perceived stress reduction in survey data. Beta-caryophyllene uniquely binds to CB2 receptors, a property that may underpin anecdotal reports of reduced inflammation-related discomfort. Terpinolene’s association with fresh, effervescent aroma is often linked to creative, mentally energizing sessions.
Minor cannabinoids and sulfur-containing volatiles can also shape the experience. Trace levels of CBG in the 0.2–0.6% range are common in high-THC hybrids and may contribute to mental clarity. Sulfur compounds, if present in tiny amounts, can intensify citrus notes without reading as skunky, adding sparkle to the nose. These micro-components are sensitive to drying conditions and can be lost if temperatures run high.
Growers seeking maximal terpene expression should prioritize stable late-flower temperatures and a slow dry. Keeping post-harvest temperatures near 16°C and relative humidity near 60% for 10–14 days preserves monoterpenes better than rapid drying. Avoiding direct airflow on colas reduces localized desiccation that can mute top notes. These controls can make the difference between a good and a great jar for terpene-rich cultivars like Dave's Who 13.
Experiential Effects and Use Cases
Consumers typically describe Dave's Who 13 as uplifting, clear-headed, and fast-acting. Onset often occurs within 2–5 minutes with inhalation, peaking around 15–25 minutes, and tapering over 90–180 minutes depending on dose and tolerance. The mental effect centers on alertness and positive mood without heavy body sedation. Many report enhanced focus suitable for creative tasks or light social activity.
Physically, the cultivar tends to feel light and mobile, with minimal couchlock at moderate doses. Some users note a gentle, tension-releasing effect in the shoulders and neck, likely tied to the caryophyllene and humulene contributions. Increased heart rate and dry mouth are common cannabis side effects and may be noticed here as well. As with other sativa-dominant profiles, a small subset of users may experience transient edginess if they overshoot their comfortable dose.
Anecdotal use cases include daytime productivity, brainstorming sessions, and pre-exercise motivation for low-intensity activities such as walking or yoga. The strain’s clarity can complement tasks requiring pattern recognition or divergent thinking, like design or writing. For social settings, the mood lift and conversational ease are frequently praised. Pairing with caffeine is common but should be approached carefully to avoid overstimulation.
Dose titration is central to a positive experience. Novices may start with 2–5 mg THC inhaled, observing effects for 15–20 minutes before redosing. Experienced consumers often find 10–20 mg inhaled sufficient for a robust but functional session. Exceeding personal tolerance increases the chance of short-lived anxiety, a general cannabis consideration rather than a strain flaw.
Compared to heavier indica-leaning cultivars, Dave's Who 13 offers a brighter, more cognitive-forward profile. Sleepiness is unlikely unless consumed toward the end of a long day or at high doses. The strain’s appeal lies in its ability to energize without jitter, assuming a terpene profile dominated by citrus-pine notes. This balance makes it a reliable daytime companion for many users.
Potential Medical Applications
Medical users often pursue sativa-leaning cultivars to address mood, motivation, and fatigue without sedation. While clinical evidence specific to Dave's Who 13 is not available, general research and patient-reported outcomes support several plausible use cases. These include short-term relief from stress and low mood, increased focus for certain attention-related challenges, and mild analgesia for tension-type discomfort. The cultivar’s terpene cluster may also contribute to perceived anxiolytic effects at low to moderate doses.
Beta-caryophyllene’s affinity for CB2 receptors has been studied for its anti-inflammatory potential in preclinical models. In the context of cannabis flower, this may translate to subtle reductions in inflammation-related discomfort when combined with THC. Limonene has been associated with enhanced mood and reduced perceived stress in survey data and small studies. Pinene’s potential to counteract short-term memory impairment is hypothesized but remains under active investigation.
Patients with fatigue-dominant conditions sometimes prefer sativa-forward profiles for daytime function. For these individuals, Dave's Who 13 may provide a gentle energy lift without clouding cognition. However, those with anxiety disorders should approach cautiously, as sativa-leaning chemotypes can, at higher doses, feel stimulating. Careful titration and setting control are advised.
Pain relief with this cultivar is reported as mild to moderate, better suited for tension headaches, muscle tightness, or activity-related soreness than severe chronic pain. Combining inhaled flower with topical or oral CBD may broaden the analgesic envelope for some patients. As always, cannabinoid therapy should complement, not replace, medical advice from qualified clinicians. Documentation of individual responses helps fine-tune regimens over time.
Sleep support is not a primary strength of Dave's Who 13. Nonetheless, some users experience post-peak relaxation that can aid unwinding in the evening. For insomnia, more sedating chemotypes or formulations rich in linalool and myrcene may be preferable. Matching the strain to the therapeutic goal improves outcomes and reduces side effects.
Comprehensive Cultivation Guide
Dave's Who 13 performs best when treated like a vigorous, sativa-leaning photoperiod cultivar with disciplined canopy management. Start seeds or rooted clones in a stable environment at 24–26°C with 60–70% relative humidity and gentle airflow. In coco or rockwool, target a root zone EC of 1.0–1.4 mS/cm in early veg, rising to 1.6–1.8 mS/cm as plants establish. Soil and living soil blends should be buffered and aerated, with pH near 6.3–6.7.
Vegetative growth thrives under 18/6 or 20/4 light schedules. Aim for 400–600 µmol/m²/s PPFD in veg, gradually increasing to 700–1,000 µmol/m²/s in bloom. If supplementing CO2, maintain 1,000–1,200 ppm during lights-on in flower to support higher PPFD, and ensure VPD remains in the 1.0–1.2 kPa range. Without CO2, cap PPFD closer to 800–900 to avoid diminishing returns.
Training is essential due to the cultivar’s stretch. Top once at the fifth or sixth node to create two mains, then apply low-stress training to open the canopy. A single layer of trellis net at 8–12 inches above the pot rim helps organize shoots and distribute colas evenly. For SCROG, plan on 1–2 plants per 2x4 ft area depending on veg time.
Transition to flower with a clean lollipop and selective defoliation to remove shaded interior growth. Expect a 1.8x–2.4x stretch in the first 2–3 weeks after flip; guide tops to fill open squares without stacking nodes too densely. Avoid aggressive defoliation late in stretch, which can slow momentum and reduce bud sites. Maintain day temperatures at 24–26°C and nights at 19–21°C for tight internoding.
Nutrient demands follow a classic sativa-leaning curve. Keep nitrogen moderate in early bloom, then taper gradually after week 4 while supplying ample potassium and adequate magnesium and calcium. In soilless systems, bloom EC often lands between 1.8 and 2.2 mS/cm depending on cultivar appetite and runoff readings. Maintain pH at 5.7–6.1 in hydro/coco and 6.2–6.7 in soil.
Irrigation frequency should match container size and media. In coco, smaller, more frequent fertigations produce better oxygenation and steady nutrient delivery; aim for 10–20% runoff to prevent salt accumulation. In soil, water to full saturation with adequate dry-back, avoiding the extremes of drought stress. Monitor plant cues—slight leaf praying suggests a good energy balance, while clawing or tip burn signals overfeeding.
Flowering time for Dave's Who 13 typically falls in the 9–11 week range depending on phenotype and environment. Many growers report optimal harvest around 67–75 days from flip, with earlier cuts emphasizing heady brightness and later cuts deepening body tone. Trichome assessment remains the gold standard—harvest when the majority are cloudy with 5–15% amber for a balanced profile. Flushing practices vary; in inert media, a 7–10 day low-EC finish can improve burn and flavor.
Environmental control is central to quality. Keep VPD near 1.0–1.2 kPa in early bloom, then 0.9–1.1 kPa mid-bloom, tapering to 0.8–1.0 kPa in late bloom to protect terpenes. Relative humidity should move from 55–60% early to 45–50% in the final two weeks. Canopy temperatures above 28–29°C risk terpene loss and foxtailing under intense light.
Pest and pathogen management should be preventive. Sativa canopies can be airy, but dense scrogs still face risks from powdery mildew and botrytis if humidity spikes. Implement an IPM program with regular scouting, sticky cards, and beneficials such as Amblyseius swirskii or A. californicus for mites and Orius for thrips. Biologicals like Bacillus subtilis and Bacillus amyloliquefaciens can be rotated for foliar protection in veg; discontinue foliar sprays by week 3 of bloom.
Outdoor cultivation suits warm, dry climates with long seasons. In temperate zones, expect harvest from early to late October depending on phenotype and latitude; greenhouses help extend finish and control moisture. Plant in full sun with well-draining, amended soil, and employ early topping to tame height. Stake or trellis proactively to support late-season weight and weather.
Drying and curing make or break terpene-rich cultivars. Target 10–14 days at 60°F (15.5–16°C) and 60% RH with minimal direct airflow on flowers. After a stem-snap dry, trim and jar with 58–62% humidity packs, burping as needed to maintain a 0.55–0.65 water activity. Store in the dark at 60–68°F to preserve volatiles and color.
Yield potential responds to environment and technique. Indoor, a well-managed SCROG can produce roughly 35–65 g/ft² (1.25–2.3 oz/ft²) under 700–900 µmol/m²/s, with CO2 pushing the upper end. Outdoor, large, trained plants in rich soil can exceed 500–1,000 g per plant in ideal conditions. Prioritizing even canopy development and light distribution drives the best results.
Finally, cleanliness and record-keeping sustain success. Sanitize tools, rotate IPM modes of action, and log environmental data to spot trends. Incremental adjustments—5–10% changes to light, feed, or airflow—are preferable to drastic swings. Over time, these habits turn a good run of Dave's Who 13 into a great one.
Yield, Harvest Timing, and Post-Harvest Handling
Most indoor growers targeting quality over sheer volume can expect 350–500 g/m² under high-efficiency LED lighting with disciplined training. With CO2 enrichment and optimized light maps, yields above 550 g/m² are attainable for skilled operators. Outdoor yields vary widely by season length and training, but 0.5–1.0 kg per plant is feasible in fertile, sunny settings. These ranges assume healthy plants and proper environmental management.
Harvest timing depends on desired effect. For a more electric, cerebral profile, harvest when trichomes are fully cloudy with minimal amber, often around days 63–68. For a slightly deeper, more rounded effect with added body, allow 5–15% amber, approaching days 70–75. Going beyond that window risks terpene loss and diminished brightness.
Pre-harvest practices can influence the final jar. Reducing EC during the last 7–10 days in inert media helps clear residual salts and improve combustion character. Some growers dim lights 10–20% in the final 3 days to reduce heat stress and preserve terpenes, though this is optional. Darkness periods prior to chop are debated; consistent, cool finishing conditions are the more reliable lever.
Drying is best conducted slowly to protect monoterpenes like terpinolene and limonene. Aim for 60°F/60% RH with gentle, indirect airflow and adequate spacing between branches. Target a 10–14 day dry until small stems snap and larger branches bend with a soft crack. Overly fast drying leads to harshness and muted citrus notes.
Curing refines flavor and smooths the burn. After trimming, jar with humidity control packs to stabilize at 58–62% RH, opening jars daily for the first week to release moisture. Over 3–6 weeks, chlorophyll and grassy volatiles dissipate, while citrus-pine character becomes more distinct. Properly cured flower maintains enjoyable flavor for 2–3 months under good storage.
Long-term storage should prioritize low light, stable temperature, and airtight containers. Glass remains the gold standard for preserving aroma and preventing odor cross-contamination. Avoid plastic bags for long-term storage, as they can transmit odor and allow moisture exchange. For large volumes, consider food-safe, gasketed bins with humidity control and periodic quality checks.
Environmental Controls, IPM, and Troubleshooting
Dialed-in environmental parameters will maximize Dave's Who 13’s potential. In veg, maintain 24–26°C with 60–70% RH and a VPD near 0.8–1.0 kPa for steady growth. In early bloom, 24–26°C with 50–55% RH balances transpiration and pathogen suppression. Late bloom benefits from 21–24°C and 45–50% RH to preserve terpenes and density.
Light intensity should be mapped with a PAR meter to ensure even coverage. Keep PPFD at 700–900 µmol/m²/s in flower without CO2, and 900–1,100 µmol/m²/s with 1,000–1,200 ppm CO2. Maintain uniform canopy height to avoid hot spots and larfy lower yields. Photo bleaching at the tops signals excessive intensity or insufficient distance.
A proactive IPM schedule beats reactive treatments. Introduce beneficial mites like Amblyseius swirskii or californicus early, especially if you’ve had past mite or thrip issues. Rotate biological fungicides such as Bacillus subtilis and Streptomyces lydicus in veg, ceasing foliar sprays by week 3 of bloom. Sanitize spaces between runs and quarantine new plant material for 10–14 days.
Powdery mildew risk rises with stagnant air and leaf wetness. Maintain strong but non-drying airflow, pulling clean intake and exhausting stale air. Defoliate strategically to open up dense nodes, focusing on interior fans that shade bud sites. If PM appears, address environment first, then consider safe-in-veg treatments and prune affected tissue.
Common nutrient issues present predictably. Overfeeding reveals itself as leaf tip burn and dark, clawed foliage; reduce EC by 10–20% and increase runoff. Calcium and magnesium shortages show as interveinal chlorosis and spotty necrosis, especially under LED; supplement with 0.3–0.5 EC of cal-mag as needed. Potassium deficiency late bloom can cause margin burn and reduced density; confirm with runoff EC and adjust bloom boosters judiciously.
Root health underpins everything. In coco and hydro, maintain solution temperatures at 18–21°C and ensure ample dissolved oxygen via aeration or frequent fertigations. Avoid standing water and ensure containers have adequate drainage. Compacted media suffocates roots, leading to slow growth and susceptibility to pathogens.
Troubleshooting stretch and structure is a matter of timing. If plants overshoot height, supercrop pliable tops early in week 2 of flower to redistribute auxin and level the canopy. Install a second net if necessary to support reoriented shoots. Plan your next run with earlier topping and a shorter veg period to match the cultivar’s stretch profile.
Post-harvest issues often trace back to environment. Hay-like aroma or muted citrus typically means too-fast drying or high temperatures; slow the process, lower temps, and reduce direct airflow next run. Harshness is commonly linked to insufficient cure or residual salts; extend the cure and consider a longer, lower-EC finish. Small, incremental changes reliably improve quality over time.
Consumer Guidance, Dosing, and Safety
For first-time consumers of Dave's Who 13, start low and go slow. Inhaled doses of 2–5 mg THC allow you to gauge the uplifting, cognitive effects without overshooting. Wait 15–20 minutes before considering a second draw, as peak effects typically emerge within that window. Experienced users can explore 10–20 mg inhaled for pronounced but functional effects.
Time of day matters for sativa-leaning profiles. Morning or early afternoon use aligns with the cultivar’s energizing character and minimizes sleep disruption. Pairing with food can moderate onset intensity for some users. Hydration and a light snack help reduce dry mouth and lightheadedness.
Individuals sensitive to stimulation should plan their session in a comfortable setting. Soothing music, a calm environment, and mindful breathing can counter transient edginess. If you overconsume, remember that unpleasant sensations are temporary; rest, hydration, and time are the best remedies. Avoid mixing with high caffeine if you are prone to anxiousness.
Always store cannabis securely and responsibly. Keep products out of reach of children and pets, in clearly labeled containers. Avoid driving or operating machinery while under the influence. If using cannabis for medical purposes, consult a healthcare professional, especially if you take medications that may interact.
Comparisons to Related Sativa Varieties
Compared to classic Haze derivatives, Dave's Who 13 presents a more modern, polished expression with denser stacking and a faster finishing window. Where old-school Hazes may push 12–14 weeks, Dave's Who 13 commonly completes in 9–11 weeks, improving production schedules. Its terpene profile leans bright citrus-pine over incense-heavy spice, though peppery caryophyllene still grounds the experience. This makes it more approachable for contemporary palates.
When compared to limonene-dominant sativas like some Jack-derived cuts, Dave's Who 13 often shows a broader aroma band with tertiary floral or herbal notes. The effect feels less jitter-prone at moderate doses, likely due to a more balanced terpene array. Density and resin coverage are competitive, supporting attractive bag appeal. It occupies the space between classic Jack brightness and Haze complexity.
Against terpinolene-forward cultivars like some modern Cookies x Haze crosses, Dave's Who 13 holds its own on top-note vibrancy. The difference appears in structure—Dave's Who 13 tends toward elongated spears with a favorable calyx-to-leaf ratio, easing trim. In side-by-side grows, canopy management and environmental tuning ultimately decide winners more than inherent genetic ceilings. With skilled handling, Dave's Who 13 can deliver equal or superior terpene intensity.
For consumers choosing between daytime strains, the decision often comes down to flavor preference and dose tolerance. If you favor lemon-pine with a crisp, clean finish and want functional clarity, Dave's Who 13 is a strong candidate. Those seeking deeper, incense-driven profiles may prefer classic Hazes or hybrids with more myrcene and linalool. As always, sampling small amounts helps tailor choices to personal chemistry.
Summary of Key Facts
Breeder: James Loud Genetics. Heritage: Mostly sativa. Expected flowering time: 9–11 weeks indoor, early to late October outdoor depending on latitude. Reported effects: uplifting, clear-headed, creative, and functional.
Aroma and flavor: bright citrus, pine, and herbal-floral notes with peppery undertones; terpenes likely led by terpinolene or limonene with pinene and caryophyllene support. Potency: frequently in the 18–26% THC band for modern sativa-dominant cultivars; CBD typically <0.5%. Total terpene targets: 1.5–3.0% common in high-quality runs, with potential to exceed under excellent conditions.
Cultivation highlights: 1.8x–2.4x stretch post-flip; thrives under 700–900 µmol/m²/s PPFD (higher with CO2); prefers moderate N, strong K in bloom; responsive to SCROG and early topping. Environmental best practices: 24–26°C early bloom, 21–24°C late bloom; RH 55→45%; VPD ~1.0 kPa. Dry and cure at 60°F/60% RH for 10–14 days, then jar at 58–62% RH.
Ideal users: daytime consumers, creative professionals, and medical patients seeking mood lift and functional clarity. Safety: start low (2–5 mg THC inhaled), avoid mixing with high caffeine if sensitive, and practice secure storage. With attentive cultivation and careful dosing, Dave's Who 13 delivers a vivid, modern sativa experience.
